Guided Therapeutics (GTHP) Cost of Revenue (2012 - 2025)
Guided Therapeutics (GTHP) posted Cost of Revenue of $132000.0 for Q4 2025, up 428.0% sequentially from $25000.0 in Q3 2025, and up 4300.0% YoY from $3000.0 in Q4 2024.
Guided Therapeutics (GTHP) Cost of Revenue (2012 - 2025) Analysis & Trends
Guided Therapeutics has reported Cost of Revenue for 14 years, with the latest figure at $132000.0 in Q4 2025.
- Quarterly Cost of Revenue rose 4300.0% year-over-year to $132000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $195000.0 (up 3800.0% YoY) and the FY2025 annual result came in at $196000.0, up 3820.0% from the prior year.
- Cost of Revenue rose to $132000.0 in Q4 2025 per GTHP's latest filing, from $25000.0 in the prior quarter.
- Over five years, Cost of Revenue peaked at $132000.0 in Q4 2025 and troughed at $1000.0 in Q1 2022.
- A 5-year average of $28857.1 and a median of $17500.0 in 2021 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2024 and 2025: Cost of Revenue slumped 81.25% in 2024, then surged 4300.0% in 2025.
- Over 5 years, Cost of Revenue stood at $19000.0 in 2021, then jumped by 315.79% to $79000.0 in 2022, then tumbled by 79.75% to $16000.0 in 2023, then plunged by 81.25% to $3000.0 in 2024, then soared by 4300.0% to $132000.0 in 2025.
- According to Business Quant data, Cost of Revenue over the past three periods registered $132000.0, $25000.0, and $38000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 132,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 79,000.00 |
| Dec 31, 2022 | 79,000.00 |